These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25739723)

  • 1. Public healthcare interests require strict competition enforcement.
    Loozen EM
    Health Policy; 2015 Jul; 119(7):882-8. PubMed ID: 25739723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Getting the product right: how competition policy can improve health care markets.
    Sage WM
    Health Aff (Millwood); 2014 Jun; 33(6):1076-82. PubMed ID: 24841884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition rules and health care players: principles and consequences.
    Fornaciari D; Callens S
    Int J Health Care Qual Assur; 2012; 25(5):379-86. PubMed ID: 22946238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competition policy for health care provision in the Netherlands.
    Schut FT; Varkevisser M
    Health Policy; 2017 Feb; 121(2):126-133. PubMed ID: 27923494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competition policy in health care markets: navigating the enforcement and policy maze.
    Gaynor M
    Health Aff (Millwood); 2014 Jun; 33(6):1088-93. PubMed ID: 24841882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preconditions for efficiency and affordability in competitive healthcare markets: are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland?
    van de Ven WP; Beck K; Buchner F; Schokkaert E; Schut FT; Shmueli A; Wasem J
    Health Policy; 2013 Mar; 109(3):226-45. PubMed ID: 23399042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembled Products: The Key to More Effective Competition And Antitrust Oversight in Health Care.
    Sage WM
    Cornell Law Rev; 2016; 101(3):609-700. PubMed ID: 27062731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitrust policy in the Dutch health care system and the relevance of EEC competition policy and U.S. antitrust practice.
    Schut FT; Greenberg W; van de Ven WP
    Health Policy; 1991 Apr; 17(3):257-84. PubMed ID: 10170742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining hospital markets for antitrust enforcement: new approaches and their applicability to The Netherlands.
    Varkevisser M; Capps CS; Schut FT
    Health Econ Policy Law; 2008 Jan; 3(Pt 1):7-29. PubMed ID: 18634630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Health Care Systems and the Emerging Influence of European Union Competition Policy.
    Morton AJB
    J Health Polit Policy Law; 2021 Jun; 46(3):467-486. PubMed ID: 33647978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Workable competition in health care: prospects for the Dutch design.
    Schut FT
    Soc Sci Med; 1992 Dec; 35(12):1445-55. PubMed ID: 1485192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care and competition law and policy: a year-long dialogue.
    Razor J
    Bull Am Coll Surg; 2003 Aug; 88(8):8-11. PubMed ID: 23581089
    [No Abstract]   [Full Text] [Related]  

  • 13. The Netherlands: health system review.
    Schäfer W; Kroneman M; Boerma W; van den Berg M; Westert G; Devillé W; van Ginneken E
    Health Syst Transit; 2010; 12(1):v-xxvii, 1-228. PubMed ID: 21132996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing economic freedom against social policy principles: EC competition law and national health systems.
    Mossialos E; Lear J
    Health Policy; 2012 Jul; 106(2):127-37. PubMed ID: 22502932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of EU competition law in health care and the 'undertaking' concept.
    van de Gronden JW; Guy M
    Health Econ Policy Law; 2021 Jan; 16(1):76-89. PubMed ID: 32349857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Competition in healthcare and its implications for the patient].
    Hammel L
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(10):632-4; discussion 634. PubMed ID: 20120191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Should I Buy or Should I Grow?" How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic.
    Belackova V; Maalsté N; Zabransky T; Grund JP
    Int J Drug Policy; 2015 Mar; 26(3):296-310. PubMed ID: 25655217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to make market competition work in healthcare.
    Holman KH; Hayward RA
    Med Care; 2011 Mar; 49(3):240-4; discussion 245-7. PubMed ID: 21301367
    [No Abstract]   [Full Text] [Related]  

  • 19. [Legal implications of the limitations of competition in healthcare systems].
    Dettling HU
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(10):625-31; discussion 634. PubMed ID: 20120190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for regulated competition in the health care system: what can China learn from Russia's experience?
    Xu W; Sheiman I; van de Ven WP; Zhang W
    Health Policy Plan; 2011 May; 26(3):199-209. PubMed ID: 20817697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.